DIAGNOSTIC VALUE OF BRAIN DAMAGE MARKERS LEVELS IN SERUM DURING THE FIRST 24 HOURS OF THE BRAIN ISCHEMIC STROKE
DOI:
https://doi.org/10.14739/2310-1210.2014.6.35764Keywords:
Brain Ischemic Stroke, Acute Period, Neuron Specific Enolase, Myelin Basic Protein, S100 ProteinAbstract
Aim. To determine the brain damage markers levels in serum during the first 24 hours of the brain ischemic stroke.
Methods and results.115 patients in acute period of brain ischemic stroke were examined.
Conclusion. It was established that development of brain ischemic stroke is followed by increase of serum level of neuronspecificenolase(Δ%=1010; p<0,05), myelin basic protein (Δ%=440; p<0,05) and S100 protein (Δ%=310; p<0,05) in the first 24 hours of disease onset.
References
Barbieri, A., Giuliani, E., Carone, C., et al. (2013). Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the stroke Markers (STROMA) study.MinervaAnestesiol, 79(7), 750–757.
Zaheer, S., Beg, M.,Rizvi, I., et al. (2012).Correlation between serum neuron specific enolase and functional neurological outcome in patients of acute ischemic stroke.Indian J ClinBiochem, 27(2), 186–190.
Bharosay, A., Bharosay, V. V.,Varma, M., et al. (2013).Correlation of brain biomarker neuron specific enolase (NSE) with degree of disability and neurological worsening in cerebrovascular stroke.Ann Indian AcadNeurolVol., 16(4), 504–508.
Gilhus, N. E. (2011). European Handbook of Neurological Management: Volume 1, 2nd Edition.Blackwell Publishing Ltd.
Petzold,A.,Michel, P., Stock, M., et al. (2008). Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome.CerebrovascDisVol, 17(4), 196–203.doi: 10.1016/j.jstrokecerebrovasdis.2008.02.002.
Mukherjee, D., &Patil, C.G. (2011). Epidemiology and the global burden of stroke.WorldNeurosurg., 76(6), 85–90.doi: 10.1016/j.wneu.2011.07.023.
Brouns, R.,DeVil, B., Cras, P., et al. (2010).Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.Clin Chem., 56(3), 451–458.doi: 10.1373/clinchem.2009.134122.
Hjalmarsson, C.,Bjerke, M., Andersson, B., et al. (2014).Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke.J Cent NervSyst Dis, 19(6), 51–58.doi: 10.4137/JCNSD.S13821.
Purrucker, J. C., Herrmann, O., Lutsch, J. K., et al. (2014). Serum protein S100β is a diagnostic biomarker for distinguishing posterior circulation stroke from vertigo of nonvascular causes. EurNeurol, 16(72), 278–284.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)